Medisprudence delivers physician-authored medical case intelligence: IME report deconstruction, case viability screening, defense vulnerability analysis, Defense Medical Lens pre-mediation reports, expert readiness briefs, and related intelligence documents. It does not deliver legal advice, legal strategy, damages valuation, expert testimony, expert affidavits, certificates of merit, court appearances, patient care, or independent medical examinations. All work is delivered under attorney direction.
Legal nurse consultants are registered nurses who review medical records and produce chronologies and summaries. That is valuable for extraction and organization. Medisprudence adds the physician interpretation layer — what the organized record means for causation, for the IME response, for the expert, and for the demand. More specifically, Medisprudence’s founding physician has reviewed 3,000+ US claims as a payer-side utilization-review physician under InterQual and MCG — a background no LNC firm has. Our analysis is calibrated to how defense reviewers actually evaluate records, not just what the clinical picture shows.
A medical expert witness is a testifying expert — retained for opinion, deposition, and trial. Medisprudence is a non-testifying consulting physician — retained for pre-expert case intelligence before the expert engagement. The two are complementary, not competing: Medisprudence helps you decide whether to retain an expert, which specialty you need, and what documentation must be in place before the expert reviews the file. The cost of Medisprudence is a fraction of most expert retainer entry costs.
The Defense Medical Lens is a physician-authored simulation of how a defense-side medical reviewer would evaluate the record — built from the perspective of someone who performed that exact review function. Our founding physician has applied InterQual and MCG criteria across 3,000+ US payer-side claim reviews under real claims conditions. It is calibrated against InterQual, MCG, and the medical-necessity logic that defense reviewers operate under — applied first-hand by the founding physician across those reviews. No other physician-legal consulting firm in the market has this background.
Yes. Medisprudence serves both plaintiff and defense clients under conflict-screened, separate engagements. We do not serve both sides of the same matter. Conflict checks are conducted at intake. Defense and TPA engagements are available for reserve-setting medical exposure analysis, pre-mediation medical review, and WC causation assessment.
Five services are built specifically for defense teams, TPAs, and carriers: IME Quality Review (pre-submission physician review of your defense IME before it is served), Plaintiff Expert Report Analysis (analytical deconstruction of the plaintiff's disclosed medical expert report), Medical Reserve Analysis (physician-authored medical exposure assessment for reserve decisions), UR Process Audit (denial defensibility review for bad faith defense), and Bellwether Defense Medical Screening (plaintiff pool evaluation for MDL defense coordination). All existing bilateral services — Defense Medical Lens, Case Viability Screening, Defense Vulnerability Analysis — are also available with defense framing.
Same base rates as plaintiff services. The difference is payment framing: institutional invoice terms (Net 15 or Net 30), no case-cost language, and retainer/volume arrangements available for TPAs and carriers with recurring case flow. Defense engagement is an operating expense, not a case cost advance.
Every inquiry — both plaintiff and defense — includes opposing party identification at intake. The conflict check is completed before scope confirmation. Medisprudence will not serve both sides of the same matter. If a conflict is found, the second inquiry is declined without disclosing which party or matter created the conflict. Every scope confirmation letter includes conflict-check confirmation. Full conflict policy →
No. The first step is deliberately low-friction. You send only general case facts — case type, injury, IME status, approximate record volume, deadline, and the decision you need to make. Do not send PHI by email. Medisprudence confirms scope, pricing, turnaround, and conflict status. BAA and engagement terms are confirmed before any records are transmitted.
Cross-border processing is disclosed before any records are accepted and before engagement is formed. This is a deliberate transparency policy. The BAA executed before engagement governs PHI handling under the cross-border framework. All AI-assisted extraction uses systems covered by appropriate contractual safeguards. PHI is not entered into public consumer AI tools. Records are not used for model training.
AI-assisted extraction is used in Stage 1 of the workflow — capturing dates, providers, diagnoses, procedures, and page references from medical records. This produces structured data, not intelligence. Stage 2 is physician-authored: the founding physician reviews extracted data against original records and applies all clinical intelligence layers. Every deliverable identifies AI-assisted versus physician-authored components at the component level.
No. Medisprudence does not provide independent expert testimony, expert affidavits, certificates of merit, or court-facing causation opinions. This is by design. The non-testifying consulting role is structurally distinct from the expert witness role — it eliminates conflicts, allows more candid analysis, and keeps pricing accessible.
Case Viability Screening (CVA): 72 hours standard. IME Report Deconstruction: 3–5 business days. Defense Medical Lens add-on: 48 hours. Defense Medical Lens standalone: 3–4 days. Full Intelligence Report (CMIP): 5–10 business days depending on record volume. Rush options are available and confirmed at scope.
Case Viability Screening starts at $350. IME Report Deconstruction starts at $500. Defense Medical Lens starts at $400 as an add-on, $950 standalone. Full Intelligence Report (CMIP) starts at $1,500. All fees are confirmed at scope. No contingent-fee arrangements are available. Bundled packages are available from $800 — below à la carte rates, structured as a single case cost advance.
Yes — and this is how most plaintiff attorneys structure Medisprudence fees. In a contingency-fee practice, Medisprudence fees are advanced as case costs against the matter and recovered from settlement proceeds, the same way you would advance expert consultation, medical record retrieval, or investigation costs. Medisprudence is paid at invoice — the case cost recovery is your firm’s internal accounting decision, not a Medisprudence payment arrangement. This means there is no new budget category required: Medisprudence fees fit the case cost line item that already exists in every plaintiff practice.
For established attorney clients on confirmed retainer arrangements, deferred billing — where the engagement fee is invoiced at case resolution rather than upon delivery — can be discussed at scope confirmation. This is not available for first-time engagements. Contact Medisprudence to discuss whether your firm’s case volume and practice area make a deferred billing arrangement appropriate.
Start with a no-PHI inquiry — describe the case type and the decision you need to make.
Request Case Review Send a Message